What's Happening on the Hill? Dr. Rachel Tate ( @uptoTate) talks with Dr. Angus Worthing about #ACR22 Convergence Session # 12S119 about legislative updates. https://t.co/zd6SVtSqrc https://t.co/7Y8ylkTSbx

• https://bit.ly/3EP0y6m

Patient Reported Outcomes in PsA Using Novel IL 17A Inhibitor Dr. Sims ( @DrCassySims) discusses abstract 0199 presented at #ACR22. https://t.co/L14WoimRE6 https://t.co/LhgyE1LwGa

• https://bit.ly/3Xp5Z3w

RA Topic Panel RheumNow recaps the best & most interesting data presented at #ACR22 in RA. Panelists: Drs.Conway, Najm, Liew, Pope, Segan Follow: @RichardPAConway @AurelieRheumo @drdavidliew @Janetbirdope @JulianSegan https://t.co/6SAlQwcPS0 https://t.co/kSZgTQs6Ns

• https://bit.ly/3EPFOLV

Infections in pre-RA: a cause or a consequence? Dr. Aurelie Najm ( @AurelieRheumo) discusses oral presentation abstract #0535 from #ACR22. https://t.co/ajI2zo4KRA https://t.co/cHkzNshVcn

• https://bit.ly/3tLxmqy

Proposed Cancer Screening for Inflammatory Myositis Patients 11/12's plenary session features a novel proposal on how and which patients with Idiopathic Inflammatory Myopathy (IIM) should be screened for cancer. https://t.co/uMhJu6eQt1 https://t.co/JeeeGadP4d

• https://bit.ly/3EPy6kZ

#ACR22 Appraisal, Praise & Critique Dr. Cush talks ACR22, the highs and the lows. https://t.co/NoRqvFaBKl https://t.co/0b5IlAojVq

• https://bit.ly/3Orff2N

Exciting Data for SLE: Plenaries from #ACR22 Dr. Michael Putman ( @EBRheum ) shares SLE updates shared at #ACR22. https://t.co/e6tCwLdHMS https://t.co/u7yoE4T9Zs

• https://bit.ly/3GuO85c

Dual target blockade may be better than one in SLE Dr. Yusof ( @Yuz6Yusof) discusses abstracts #L07 and #1001 presented at #ACR22. https://t.co/0SzQAorzZy https://t.co/fZ6CpFNSWI

• https://bit.ly/3UNPImM

Lupus Topic Panel Join RheumNow to recap the best and most interesting data presented at #ACR22 in the area of SLE. Panelists: @KDAO2011 @bella_mehta @Yuz6Yusof @ericdeinmd @EBRheum @RHEUMarampa @Janetbirdope https://t.co/7oUZcQK27U https://t.co/1JClivUJpk

• https://bit.ly/3hQ1nTz